TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Sanofi-Aventis Norge AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
66,833
|
65,548
|
73,657 |
Financial expenses |
116
|
124
|
102 |
Earnings before taxes |
3,736
|
5,657
|
2,916 |
Total assets |
31,303
|
37,887
|
32,707 |
Current assets |
31,076
|
37,645
|
32,397 |
Current liabilities |
30,834
|
33,047
|
17,238 |
Equity capital |
469
|
4,840
|
15,468 |
- share capital |
162
|
173
|
182 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
1.5%
|
12.8%
|
47.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
5.6%
|
8.6%
|
4.0% |
Return on assets (ROA) |
12.3%
|
15.3%
|
9.2% |
Current ratio |
100.8%
|
113.9%
|
187.9% |
Return on equity (ROE) |
796.6%
|
116.9%
|
18.9% |
Change turnover |
5,449
|
-4,240
|
4,047 |
Change turnover % |
9%
|
-6%
|
6% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.